4.8 Article

Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis

期刊

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 140, 期 5, 页码 1617-1621

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jacs.7b13361

关键词

-

资金

  1. ETH Zurich
  2. Swiss National Science Foundation [310030B_163479/1, SINERGIA CRSII2_160699/1]
  3. ERC Advanced Grant Zauberkugel [670603]
  4. Kommission fur Technologie und Innovation [17072.1]
  5. Novartis Foundation for medical-biological Research

向作者/读者索取更多资源

We present the first direct comparative evaluation of an antibody drug conjugate and of a small molecule drug conjugate for cancer therapy, using chemically defined products which bind with high-affinity to carbonic anhydrase IX, a marker of tumor hypoxia and of renal cell carcinoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据